[Phenobarbital in the newborn (author's transl)]. 1982

D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard

Neonates with severe cerebral damage are usually given phenobarbital. The authors study the various means of administration and the influence of term and concomitant mannitol administration on the plasma levels of the drug. They recommend the intravenous administration of a load dose and show that phenobarbital blood levels are significantly less in prematures or in children who have been given mannitol.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
January 1978, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
January 1979, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
July 1980, Zeitschrift fur Kinderchirurgie und Grenzgebiete,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
January 1980, Monatsschrift fur Kinderheilkunde,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
May 1977, Anales espanoles de pediatria,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
January 1977, Padiatrie und Padologie,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
November 1980, Zhonghua fang she xue za zhi Chinese journal of radiology,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
July 1981, Klinische Padiatrie,
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
January 1981, Deutsche medizinische Wochenschrift (1946),
D Alix, and C Riche, and Y Guedes, and P Parent, and M Curunet, and G Conan, and M Bourin, and H Gouedard
April 1977, Anales espanoles de pediatria,
Copied contents to your clipboard!